![]() With biobanking experts and leaders (and end-users) from Genentech, Pfizer, AstraZeneca, Boehringer Ingelheim, Spanish National Cancer Research Centre, Wales Cancer Bank, Chernobyl Tissue Bank (Imperial College London) and WHO discussing the critical challenges and opportunities for successful biosample management in human disease research, don't miss the world's leading biobanking conference designed for both biobanks and big pharmaceutical and biotech companies.Ĭurrently, heterogeneity in the way biobanks are managed is one of the biggest obstacles to widespread biomarker and targeted therapy development. ![]()
0 Comments
Leave a Reply. |